March 10, 2011
Panel to discuss challenges of genomics to individualize drug therapy
“Using Genomics to Individualize Drug Therapy: Technical, Clinical and Ethical Challenges” will be the topic of a upcoming panel discussion by UW researchers at the UW Health Sciences. The Institute of Translational Health Sciences is sponsoring the discussion.
The one-hour program begins at noon, Monday, March 14 in Turner Auditorium, D-209, UW Health Sciences. The event is free and open to all.
The panelists will be:
- Kenneth Thummel, professor and chair of pharmaceutics
- Wylie Burke, professor and chair of bioethics and humanities
- Rose James, acting assistant professor of bioethics and humanities.
The speakers are all members of the Northwest-Alaska Pharmacogenomics Research Network and the Center for Genomics and Healthcare Equality.
If you are unable to attend in person, you can watch or listen to a streaming video or audiocast on the Institute of Translational Health Sciences website. If you are a Mac user and unable to view the video, please install the free application Flip4Mac or try the VLC media player.
The Institute of Translational Health Sciences brings together researchers from the UW, Fred Hutchinson Cancer Research Center, Seattle Children’s Research Institute, Seattle Cancer Care Alliance, Benaroya Research Institute of Virginia Mason Hospital, Group Health Research Institute, Northwest Association of Biomedical research, and several regional partners. The ITHS is supported by National Institutes of Health funding from the National Center for Research Resources. ITHS is working to bring promising results from biomedical scientific research into clinical testing and patient-care applications, with the hope of reducing or eliminating disease.
